ArticleChemical science2026
Multitopic acid modulation unlocks a new dimensionality in defect-engineered MOFs.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Defect engineering is a powerful strategy to tailor the physicochemical properties of metal-organic frameworks (MOFs). Among various approaches, modulation synthesis - typically employing monotopic modulators - has emerged as the most widely used method to introduce structural defects. However, conventional modulation strategies aiming for high defect densities typically rely on using large quantities of monocarboxylic acids and/or strong acidity. Herein, we introduce a third dimension to modulate the defects of MOFs by employing multitopic carboxylic acids as modulators, wherein the topicity of the modulator exceeds that of the pristine linker. Using UiO-66 as a model system, multitopic modulators with varying topic numbers and carboxylate positions significantly influence defect incorporation. In particular,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.